Financials & Filings Investors Investor Relations Overview Press Releases Events & Presentations Corporate Governance Financials & Filings SEC Filings Annual Reports Quarterly Results Key Ratios Stock Information Investor FAQs Contact Us Financials & Filings First Quarter Financial Results Show all 2023 First Quarter Arrowhead Pharmaceuticals 2023 First Quarter Results Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results Form 10-Q Proxy Statements Filing date View Jan 30, 2023 0001628280-23-001743.pdf 0001628280-23-001743.rtf 0001628280-23-001743.xls View HTML Jan 26, 2022 0001193125-22-018280.pdf 0001193125-22-018280.rtf 0001193125-22-018280.xls View HTML Form 10-K Filing date View Nov 28, 2022 View HTML 0001628280-22-030869.pdf 0001628280-22-030869.rtf 0001628280-22-030869.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Nov 22, 2021 View HTML 0001564590-21-057888.pdf 0001564590-21-057888.rtf 0001564590-21-057888.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q There are no SEC filings available.
Financials & Filings First Quarter Financial Results Show all 2023 First Quarter Arrowhead Pharmaceuticals 2023 First Quarter Results Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results Form 10-Q Proxy Statements Filing date View Jan 30, 2023 0001628280-23-001743.pdf 0001628280-23-001743.rtf 0001628280-23-001743.xls View HTML Jan 26, 2022 0001193125-22-018280.pdf 0001193125-22-018280.rtf 0001193125-22-018280.xls View HTML Form 10-K Filing date View Nov 28, 2022 View HTML 0001628280-22-030869.pdf 0001628280-22-030869.rtf 0001628280-22-030869.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Nov 22, 2021 View HTML 0001564590-21-057888.pdf 0001564590-21-057888.rtf 0001564590-21-057888.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q There are no SEC filings available.